Journal
VETERINARY PATHOLOGY
Volume 60, Issue 4, Pages 443-460Publisher
SAGE PUBLICATIONS INC
DOI: 10.1177/03009858231166658
Keywords
CD163; F4; 80; histiocytic sarcoma; IBA1; immunohistochemistry; MAC2; morphologic variants; mouse
Categories
Ask authors/readers for more resources
Histiocytic sarcoma is a rare tumor derived from macrophages in humans, but more common in mice. Due to its diverse cellular morphologies, growth patterns, and organ distributions, it can be difficult to diagnose and differentiate from other types of neoplasia. Immunohistochemistry (IHC) is often necessary for distinguishing histiocytic sarcomas from other tumors in mice. This article provides a comprehensive overview of the cellular morphologies, growth patterns, organ distributions, and IHC labeling of 62 mouse histiocytic sarcomas, as well as differentiating features from morphologically similar tumors.
Histiocytic sarcoma is a tumor of the hematopoietic system considered to be derived from macrophages. Although rare in humans, it occurs frequently in mice. Histiocytic sarcoma can be a difficult tumor to diagnose due to its diverse cellular morphologies, growth patterns, and organ distributions. The varying morphology of histiocytic sarcomas makes it easy to confuse them with other types of neoplasia, including hepatic hemangiosarcoma, uterine schwannoma, leiomyosarcoma, uterine stromal cell tumor, intramedullary osteosarcoma, and myeloid leukemia. As such, immunohistochemistry (IHC) is often needed to differentiate histiocytic sarcomas from other common tumors in mice that they can morphologically mimic. The goal of this article is to present a broader perspective of the diverse cellular morphologies, growth patterns, organ distributions, and IHC labeling of histiocytic sarcomas encountered by the authors. This article describes these features in a set of 62 mouse histiocytic sarcomas, including the IHC characterization of the tumors using a panel of markers for the macrophage antigens F4/80, IBA1, MAC2, CD163, CD68, and lysozyme, and describes differentiating features of histiocytic sarcomas from other morphologically similar tumors. The genetic changes underlying the pathogenesis of histiocytic sarcoma in humans are beginning to be elucidated, but this is difficult due to its rarity. The higher prevalence of this tumor in mice provides opportunities to investigate mechanisms of its development and to test potential treatments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available